Skip to main content

Table 2 Embryonic phenotypes of mice treated with ethionine and SAM

From: Ethionine-mediated reduction of S-adenosylmethionine is responsible for the neural tube defects in the developing mouse embryo-mediated m6A modification and is involved in neural tube defects via modulating Wnt/β-catenin signaling pathway

 

Pregnant mice (n)

Embryos (n)

Normal n (%)

Resorption n (%)

Growth retardation n (%)

NTDs n (%)

Other malformation n (%)

SAM

36

223

207 (93.0)

6 (2.7)

10 (4.3)

0 (0)

0 (0)

Ethionine

38

261

51 (19.5)

31 (11.8)

36 (13.7)

128 (49.3)

11a4b (5.7)

Ethionine + SAM

37

246

142 (58.1)

21 (8.1)

15 (6.1)

63 (25.6)

3a2b (2.1)

  1. aCraniofacial malformation
  2. bPolydactyly